{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:31:14Z","timestamp":1790800274349,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jaac.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T19:26:05Z","timestamp":1737141965000},"page":"1148-1164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Systematic Review and Meta-Analysis: The Association Between Newer-Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-612X","authenticated-orcid":false,"given":"Cagdas","family":"T\u00fcrkmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-4414","authenticated-orcid":false,"given":"Noah","family":"Machunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-6022","authenticated-orcid":false,"given":"Alycia M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1931-3661","authenticated-orcid":false,"given":"Emilie","family":"Bougelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola M.","family":"Ludin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-1295","authenticated-orcid":false,"given":"Angharad N.","family":"de Cates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-672X","authenticated-orcid":false,"given":"Sabine","family":"Vollst\u00e4dt-Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-019X","authenticated-orcid":false,"given":"Patrick","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-1321","authenticated-orcid":false,"given":"Jasmina","family":"Burdzovic Andreas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7934-7596","authenticated-orcid":false,"given":"Jeanine","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-9866","authenticated-orcid":false,"given":"Robert A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1851-4328","authenticated-orcid":false,"given":"Graham J.","family":"Emslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-0142","authenticated-orcid":false,"given":"Sarah E.","family":"Hetrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-4063","authenticated-orcid":false,"given":"Wolfgang","family":"Viechtbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-8447","authenticated-orcid":false,"given":"Jens H.","family":"van Dalfsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjc.12333","article-title":"Global prevalence of depression and elevated depressive symptoms among adolescents: a systematic review and meta-analysis","volume":"61","author":"Shorey","year":"2022","journal-title":"Br J Clin Psychol"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaac.2018.07.896","article-title":"Systematic review and meta-analysis: adolescent depression and long-term psychosocial outcomes","volume":"58","author":"Clayborne","year":"2019","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaac.2020.07.895","article-title":"Associations of childhood and adolescent depression with adult psychiatric and functional outcomes","volume":"60","author":"Copeland","year":"2021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10036","key":"10.1016\/j.jaac.2025.01.006_bib4","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(16)00648-6","article-title":"Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"387","author":"Mokdad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2025.01.006_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2023.11.047","article-title":"Global, regional, and national burden of depressive disorders among young people aged 10-24 years, 2010-2019","volume":"170","author":"Zhao","year":"2023","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib6","first-page":"4","article-title":"Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice","volume":"25","author":"Jane Garland","year":"2016","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaac.2022.10.001","article-title":"Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders","volume":"62","author":"Walter","year":"2023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10047","key":"10.1016\/j.jaac.2025.01.006_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","article-title":"Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis","volume":"7","author":"Zhou","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib10","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","volume":"5","author":"Hetrick","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib11","article-title":"Tricyclic drugs for depression in children and adolescents","volume":"2013","author":"Hazell","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/phar.2767","article-title":"Adverse effects of antidepressant medications and their management in children and adolescents","volume":"43","author":"Strawn","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"e1","key":"10.1016\/j.jaac.2025.01.006_bib13","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1136\/ebmental-2021-300418","article-title":"Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals","volume":"25","author":"Chevance","year":"2022","journal-title":"Evid Based Ment Health"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.006_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.31887\/DCNS.2008.10.4\/plfranzen","article-title":"Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications","volume":"10","author":"Franzen","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41386-019-0411-y","article-title":"Sleep, insomnia, and depression","volume":"45","author":"Riemann","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"5 Suppl","key":"10.1016\/j.jaac.2025.01.006_bib16","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5664\/jcsm.26929","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smrv.2009.09.003","article-title":"Comorbidity of insomnia and depression","volume":"14","author":"Staner","year":"2010","journal-title":"Sleep Med Rev"},{"issue":"1-3","key":"10.1016\/j.jaac.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2011.01.011","article-title":"Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies","volume":"135","author":"Baglioni","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jaac.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.smrv.2018.10.006","article-title":"Insomnia as a predictor of mental disorders: a systematic review and meta-analysis","volume":"43","author":"Hertenstein","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/PSY.0b013e3182648619","article-title":"The bidirectional association between depression and insomnia: the HUNT study","volume":"74","author":"Sivertsen","year":"2012","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/cap.2011.0096","article-title":"Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth","volume":"22","author":"Emslie","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"10.1016\/j.jaac.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.5665\/sleep.2008","article-title":"Residual sleep disturbances in patients remitted from major depressive disorder: a 4-year naturalistic follow-up study","volume":"35","author":"Li","year":"2012","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46331","article-title":"Predictors, moderators, and mediators associated with treatment outcome in randomized clinical trials among adolescents with depression: a scoping review","volume":"5","author":"Courtney","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.006_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.mop.0000166347.53102.e7","article-title":"The treatment of adolescent depression in the era of the black box warning","volume":"17","author":"Richmond","year":"2005","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","article-title":"Suicidality in pediatric patients treated with antidepressant drugs","volume":"63","author":"Hammad","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.jaac.2025.01.006_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11920-013-0389-9","article-title":"The link between suicide and insomnia: theoretical mechanisms","volume":"15","author":"McCall","year":"2013","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/sltb.12003","article-title":"Insomnia symptoms, nightmares, and suicide risk: duration of sleep disturbance matters","volume":"43","author":"Nadorff","year":"2013","journal-title":"Suicide Life Threat Behav"},{"issue":"9","key":"10.1016\/j.jaac.2025.01.006_bib28","doi-asserted-by":"crossref","first-page":"e1160","DOI":"10.4088\/JCP.11r07586","article-title":"Meta-analysis of sleep disturbance and suicidal thoughts and behaviors","volume":"73","author":"Pigeon","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.006_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/cns.12597","article-title":"Sleep complaints as risk factor for suicidal behavior in severely depressed children and adolescents","volume":"22","author":"Lopes","year":"2016","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.5664\/jcsm.7104","article-title":"Insomnia and nightmares as markers of risk for suicidal ideation in young people: investigating the role of defeat and entrapment","volume":"14","author":"Russell","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.jaac.2025.01.006_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.genhosppsych.2018.09.011","article-title":"Sleep problems and suicide risk in youth: a systematic review, developmental framework, and implications for hospital treatment","volume":"63","author":"Kearns","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.006_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad177","article-title":"Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis","volume":"46","author":"Zhou","year":"2023","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JCP.0000000000000329","article-title":"Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis","volume":"35","author":"Alberti","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2025.01.006_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114431","article-title":"A comprehensive review and meta-analysis of neurological side effects related to second-generation antidepressants in individuals with major depressive disorder","volume":"447","author":"Zhou","year":"2023","journal-title":"Behav Brain Res"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.006_bib35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaac.2019.10.013","article-title":"Antidepressant tolerability in pediatric anxiety and obsessive-compulsive disorders: a Bayesian hierarchical modeling meta-analysis","volume":"59","author":"Mills","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.006_bib36","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","article-title":"The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.jaac.2025.01.006_bib38","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.006_bib40","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"26","key":"10.1016\/j.jaac.2025.01.006_bib41","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.006_bib42","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpsyc.61.11.1153","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder","volume":"61","author":"Wagner","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.006_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaac.2015.01.008","article-title":"A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder","volume":"54","author":"Strawn","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib44","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00004583-199211000-00011","article-title":"Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder","volume":"31","author":"Riddle","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"20","key":"10.1016\/j.jaac.2025.01.006_bib45","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","article-title":"Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial","volume":"280","author":"March","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004583-200102000-00017","article-title":"Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial","volume":"40","author":"Riddle","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00004583-200107000-00011","article-title":"Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial","volume":"40","author":"Geller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.006_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/cap.2013.0146","article-title":"A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder","volume":"24","author":"Atkinson","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/cap.2017.0099","article-title":"Desvenlafaxine versus placebo in the treatment of children and adolescents with major depressive disorder","volume":"28","author":"Atkinson","year":"2018","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1-2","key":"10.1016\/j.jaac.2025.01.006_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/cap.2006.16.59","article-title":"An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder","volume":"16","author":"Berard","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.006_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40272-018-0290-4","article-title":"A phase 3, double-blind, randomized, placebo-controlled study of vilazodone in adolescents with major depressive disorder","volume":"20","author":"Durgam","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.006_bib55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00004583-200210000-00010","article-title":"Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial","volume":"41","author":"Emslie","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.chi.0000214189.73240.63","article-title":"Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"45","author":"Emslie","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.006_bib57","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/chi.0b013e31802f5f03","article-title":"Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials","volume":"46","author":"Emslie","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib58","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/CHI.0b013e3181a2b304","article-title":"Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial","volume":"48","author":"Emslie","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.006_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/cap.2013.0096","article-title":"A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder","volume":"24","author":"Emslie","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/cap.2019.0176","article-title":"A randomized, double-blind, placebo-controlled trial of vilazodone in children and adolescents with major depressive disorder with twenty-six-week open-label follow-up","volume":"30","author":"Findling","year":"2020","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib61","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00004583-200107000-00010","article-title":"Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial","volume":"40","author":"Keller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib63","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/cap.2021.0104","article-title":"Efficacy and safety of duloxetine in children and adolescents with major depressive disorder in Japan: a randomized double-blind placebo-controlled clinical trial followed by an open-label long-term extension trial","volume":"32","author":"Saito","year":"2022","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib64","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0278-5846(90)90050-Q","article-title":"Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up","volume":"14","author":"Simeon","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib65","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.292.7.807","article-title":"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial","volume":"292","author":"March","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.jcp.0000219051.40632.d5","article-title":"A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder","volume":"26","author":"von Knorring","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.jaac.2025.01.006_bib67","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","article-title":"Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials","volume":"290","author":"Wagner","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/cap.2017.0100","article-title":"Desvenlafaxine versus placebo in a fluoxetine-referenced study of children and adolescents with major depressive disorder","volume":"28","author":"Weihs","year":"2018","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2025.01.006_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.103936","article-title":"Insomnia, anxiety and related disorders: a systematic review on clinical and therapeutic perspective with potential mechanisms underlying their complex link","volume":"3","author":"Palagini","year":"2024","journal-title":"Neurosci Appl"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S2215-0366(21)00390-4","article-title":"Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries","volume":"9","author":"Arango","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000345316","article-title":"Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review","volume":"82","author":"Offidani","year":"2013","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.006_bib72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s40501-015-0034-9","article-title":"SSRI-induced activation syndrome in children and adolescents\u2014what is next?","volume":"2","author":"Amitai","year":"2015","journal-title":"Curr Treat Options Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib73","first-page":"50","article-title":"Antidepressant-induced activation in children and adolescents: risk, recognition and management","volume":"48","author":"Luft","year":"2018","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaac.2025.01.006_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101597","article-title":"Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: a systematic review and meta-analysis","volume":"62","author":"Hertenstein","year":"2022","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jaac.2025.01.006_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2025.102049","article-title":"Cognitive behavioral therapy for insomnia across the spectrum of alcohol use disorder: a systematic review and meta-analysis","volume":"80","author":"T\u00fcrkmen","year":"2025","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jaac.2025.01.006_bib78","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jad.2024.09.017","article-title":"Cognitive behavioral therapy for insomnia to treat major depressive disorder with comorbid insomnia: a systematic review and meta-analysis","volume":"367","author":"Furukawa","year":"2024","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib79","doi-asserted-by":"crossref","first-page":"e7070","DOI":"10.1590\/1414-431x20187070","article-title":"Efficacy of cognitive behavioral therapy in children and adolescents with insomnia: a systematic review and meta-analysis","volume":"51","author":"Ma","year":"2018","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib80","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/NMD.0000000000001613","article-title":"Efficacy of cognitive behavioral therapy for insomnia for the treatment of child and adolescent anxiety and depression: a systematic review from randomized controlled trials","volume":"211","author":"Reddy","year":"2023","journal-title":"J Nerv Ment Dis"},{"issue":"10347","key":"10.1016\/j.jaac.2025.01.006_bib81","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-0327(00)00254-8","article-title":"Is antidepressant\u2013benzodiazepine combination therapy clinically more useful? A meta-analytic study","volume":"65","author":"Furukawa","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jaac.2025.01.006_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13034-020-00316-8","article-title":"Medications for sleep disturbance in children and adolescents with depression: a survey of Canadian child and adolescent psychiatrists","volume":"14","author":"Boafo","year":"2020","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae057","article-title":"Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysis","volume":"47","author":"Bushnell","year":"2024","journal-title":"Sleep"},{"key":"10.1016\/j.jaac.2025.01.006_bib85","article-title":"Use of melatonin for children and adolescents with chronic insomnia attributable to disorders beyond indication: a systematic review, meta-analysis and clinical recommendation","volume":"61","author":"Edemann-Callesen","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaac.2025.01.006_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102083","article-title":"The short-term and long-term adverse effects of melatonin treatment in children and adolescents: a systematic review and GRADE assessment","volume":"61","author":"H\u00e4ndel","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib87","doi-asserted-by":"crossref","first-page":"e1223","DOI":"10.1542\/peds.2005-1693","article-title":"Pharmacologic management of insomnia in children and adolescents: consensus statement","volume":"117","author":"Mindell","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib88","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2215-0366(23)00345-0","article-title":"Psychopharmacology in children and adolescents: unmet needs and opportunities","volume":"11","author":"Cortese","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.jaac.2025.01.006_bib89","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.sleep.2010.04.004","article-title":"Insomnia severity is an indicator of suicidal ideation during a depression clinical trial","volume":"11","author":"McCall","year":"2010","journal-title":"Sleep Med"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.006_bib90","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2019.19030267","article-title":"Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): a randomized clinical trial","volume":"176","author":"McCall","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.006_bib91","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5664\/jcsm.1472","article-title":"CBT for insomnia in patients with high and low depressive symptom severity: adherence and clinical outcomes","volume":"7","author":"Manber","year":"2011","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib92","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5665\/sleep.4410","article-title":"Effects of cognitive behavioral therapy for insomnia on suicidal ideation in veterans","volume":"38","author":"Trockel","year":"2015","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.jaac.2025.01.006_bib93","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac251","article-title":"Cognitive-behavioral therapy for insomnia prevents and alleviates suicidal ideation: insomnia remission is a suicidolytic mechanism","volume":"45","author":"Kalmbach","year":"2022","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.006_bib94","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1017\/S1092852920000073","article-title":"The increasing challenge of the possible impact of ethnicity on psychopharmacology","volume":"26","author":"Marazziti","year":"2021","journal-title":"CNS Spect"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.006_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae021","article-title":"Racial\/ethnic disparities in the trajectories of insomnia symptoms from childhood to young adulthood","volume":"47","author":"Singh","year":"2024","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.jaac.2025.01.006_bib96","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/MLR.0b013e3181271462","article-title":"Ethnicity\/race and outcome in the treatment of depression: results from STAR\u2217D","volume":"45","author":"Lesser","year":"2007","journal-title":"Med Care"},{"issue":"13","key":"10.1016\/j.jaac.2025.01.006_bib97","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1038\/npp.2013.166","article-title":"Race, genetic ancestry and response to antidepressant treatment for major depression","volume":"38","author":"Murphy","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.006_bib98","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S2215-0366(22)00041-4","article-title":"Designing clinically useful psychopharmacological trials: challenges and ways forward","volume":"9","author":"Chevance","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.006_bib99","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/ebmental-2019-300118","article-title":"Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol","volume":"23","author":"Tomlinson","year":"2020","journal-title":"Evid Based Ment Health"},{"issue":"9","key":"10.1016\/j.jaac.2025.01.006_bib100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856725000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856725000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:50:08Z","timestamp":1762314608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856725000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0890856725000139"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2025.01.006","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review and Meta-Analysis: The Association Between Newer-Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92025 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}